Subsite specificity of memapsin 2 (β-secretase):: Implications for inhibitor design
Subsite specificity of memapsin 2 (β-secretase):: Implications for inhibitor design
复制标题
DOI:
10.1021/bi015546s
复制
发表时间:
2001-08-28
期刊:
影响因子:
2.9
通讯作者:
Tang, J
中科院分区:
文献类型:
--
作者:
Turner, RT;Koelsch, G;Tang, J
Memapsin 2 is the protease known as beta -secretase whose action on beta -amyloid precursor protein leads to the production of the P-amyloid (AP) peptide. Since the accumulation of A beta in the brain is a key event in the pathogenesis of Alzheimer's disease, memapsin 2 is an important target for the design of inhibitory drugs. Here we describe the residue preference for the subsites of memapsin 2. The relative k(cat)/K-M values of residues in each of the eight subsites were determined by the relative initial cleavage rates of substrate mixtures as quantified by MALDI-TOF mass spectrometry. We found that each subsite can accommodate multiple residues. The S-1 subsite is the most stringent, preferring residues in the order of Leu > Phe > Met > Tyr. The preferences of other subsites are the following: S2, Asp > Asn > Met; S-3, Ile > Val > Leu; S-4, Glu > Gln > Asp; S-1', Met > Glu > Gln > Ala; S-2', Val > Ile > Ala; S-3', Leu > Trp > Ala; S-4', Asp > Glu > Trp. In general, S subsites are more specific than the S' subsites. A peptide comprising the eight most favored residues (Glu-Ile-Asp-Leu-Met-Val-Leu-Asp) was found to be hydrolyzed with the highest k(cat)/K-M value so far observed for memapsin 2. Residue preferences at four subsites were also studied by binding of memapsin 2 to a combinatorial inhibitor library. From 10 tight binding inhibitors, the consensus preferences were as follows: S2, Asp and Glu; S3, Leu and Ile; S-2', Val; and S-3', Glu and Gln. An inhibitor, OM00-3, Glu-Leu-Asp-Leu*Ala-Val-Glu-Phe (where the asterisk represents the hydroxyethylene tansition-state isostere), designed from the consensus residues, was found to be the most potent inhibitor of memapsin 2 so far reported (K-i of 3.1 x 10(-10) M). A molecular model of OM00-3 binding to memapsin 2 revealed critical improvement of the interactions between inhibitor side chains with enzyme over a previous inhibitor, OM99-2.